Author pages are created from data sourced from our academic publisher partnerships and public sources.
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer.
- A. Debucquoy, K. Haustermans, +12 authors J. Machiels
- Journal of clinical oncology : official journal…
- 10 June 2009
PURPOSE To characterize the molecular pathways activated or inhibited by cetuximab when combined with chemoradiotherapy (CRT) in rectal cancer and to identify molecular profiles and biomarkers that… Expand
The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients.
Treatment of metastatic colorectal cancer is based upon the assumption that metastases are homogeneous within a patient. We quantified immune cell types of 603 whole-slide metastases and primary… Expand
A new approach to the validation of tissue microarrays
- L. Goethals, C. Perneel, +6 authors K. Haustermans
- Medicine, Biology
- The Journal of pathology
- 1 April 2006
Although tissue microarrays (TMA) have been widely used for a number of years, it is still not clear how many core biopsies should be taken to determine a reliable value for percentage positivity or… Expand
Radiotherapy-Activated Cancer-Associated Fibroblasts Promote Tumor Progression through Paracrine IGF1R Activation.
Preoperative radiotherapy (RT) is a mainstay in the management of rectal cancer, a tumor characterized by desmoplastic stroma containing cancer-associated fibroblasts (CAF). Although CAFs are… Expand
Molecular responses of rectal cancer to preoperative chemoradiation.
- A. Debucquoy, L. Goethals, K. Geboes, Sarah Roels, William H Mc Bride, K. Haustermans
- Radiotherapy and oncology : journal of the…
- 1 August 2006
BACKGROUND AND PURPOSE Some rectal cancers respond well to preoperative neoadjuvant therapy while others are inherently resistant or develop resistance during the treatment. To understand the… Expand
Integration of Epidermal Growth Factor Receptor Inhibitors with Preoperative Chemoradiation
In many different cancer cell types, the epidermal growth factor receptor (EGFR) pathway becomes hyperactivated because of overproduction of the ligand, overproduction of the receptor, or… Expand
Integrating Microarray and Proteomics Data to Predict the Response of Cetuximab in Patients with Rectal Cancer
- A. Daemen, O. Gevaert, +4 authors K. Haustermans
- Biology, Medicine
- Pacific Symposium on Biocomputing
- 1 December 2007
We used a kernel-based method with Least Squares Support Vector Machines to predict RCRG based on the integration of microarray and proteomics data on To and T1. Expand
T-Cell Responses to Survivin in Cancer Patients Undergoing Radiation Therapy
Purpose: The goal of this study was to determine if radiation therapy (RT) of human cancer enhances or diminishes tumor-specific T-cell reactivity. This is important if immunotherapy is to be… Expand
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
- L. Goethals, A. Debucquoy, +7 authors K. Haustermans
- International journal of radiation oncology…
- 1 May 2006
PURPOSE To detect and quantify hypoxia in colorectal adenocarcinomas by use of pimonidazole and iododeoxyuridine (IdUrd) as extrinsic markers and carbonic anhydrase IX (CA IX), microvessel density… Expand
EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients
Background: Cetuximab has shown significant clinical activity in metastatic colon cancer. However, cetuximab-containing neoadjuvant chemoradiation has not been shown to improve tumor response in… Expand